iifl-logo

LIC MF Healthcare Fund Regular G

LIC MF Healthcare Fund Regular G

Fund Name

LIC Mutual Fund

Scheme Name

LIC MF Healthcare Fund Regular G

AMC

LIC Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

08-Feb-2019

Fund Manager

Karan Doshi

Net Assets (Rs. cr)

87.59

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

LIC MF Healthcare Fund Regular G - Nav Details

Nav Date

:  10-Dec-2025

NAV [Rs.]

:  29.0721

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

1.00% For exit within 12 months from the date of allotment. Nil - For exit after 12 months from the date of allotment.

LIC MF Healthcare Fund Regular G- NAV Chart

LIC MF Healthcare Fund Regular G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
-1.63
-2.65
-1.6
1.08
-4.43
19.42
12.15
17.02
Category Avg
-1.63
-1.5
-1.6
1.24
-1.52
22.35
16.18
13.93
Category Best
-1.34
-0.46
0.6
5.89
5.27
27.79
19.04
29.71
Category Worst
-2.65
-3.14
-3.48
-3.57
-8.41
18.45
12.07
-5.69

LIC MF Healthcare Fund Regular G- Latest Dividends

No Records Found

LIC MF Healthcare Fund Regular G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

500

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology11.47538519.86
EquityApollo HospitalsHealthcare Services5.7367234.93
EquityTorrent Pharma.Pharmaceuticals & Biotechnology5.68131304.88
EquityCiplaPharmaceuticals & Biotechnology5.56312184.78
EquityNeuland Labs.Pharmaceuticals & Biotechnology4.8524144.17
EquityDivi's Lab.Pharmaceuticals & Biotechnology4.6461583.98
EquityFortis Health.Healthcare Services4.50421023.86
EquityAurobindo PharmaPharmaceuticals & Biotechnology4.46313013.83
EquityPiramal PharmaPharmaceuticals & Biotechnology4.321983853.71
EquityAlkem LabPharmaceuticals & Biotechnology3.4151552.93
EquityAbbott IndiaPharmaceuticals & Biotechnology3.399682.91
EquityNavin Fluo.Intl.Chemicals & Petrochemicals3.2047962.75
EquityOneSource Speci.Pharmaceuticals & Biotechnology3.15177052.71
EquityArtemis MedicareHealthcare Services3.10935292.66
EquityIpca Labs.Pharmaceuticals & Biotechnology2.81166042.41
EquityConcord BiotechPharmaceuticals & Biotechnology2.75166872.36
EquityGland PharmaPharmaceuticals & Biotechnology2.73133512.34
EquityGlenmark Pharma.Pharmaceuticals & Biotechnology2.71119942.33
EquityMetropolis HealtHealthcare Services2.56114172.20
EquityDr Agarwal's HeaHealthcare Services2.46395762.11
EquityMax HealthcareHealthcare Services2.27167751.95
EquityMankind PharmaPharmaceuticals & Biotechnology2.2585771.93
EquityGlobal HealthHealthcare Services2.17149521.86
EquitySyngene Intl.Healthcare Services2.13282601.83
EquityAcutaas ChemicalPharmaceuticals & Biotechnology1.7783021.52
EquityAnthem BiosciencPharmaceuticals & Biotechnology1.69229611.45
EquityVinati OrganicsChemicals & Petrochemicals1.6187411.38
EquityLinde IndiaChemicals & Petrochemicals1.0815590.93

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
LIC Mutual Fund
Incorporation Date:
20-Apr-1994
Total Assets Managed (Cr.):
41,741.63
Trustee/s:
Mr. Pradeep Jagannath Bhi, LIC Mutual Fund Trustee P
Chairman:
NA
CEO / MD:
T.S. Ramakrishnan, Ravi Kumar Jha
CIO:
NA
President:
NA
Director/s:
Raghunandan Maluste, Vijay Sharma, Sanjay Achyutrao Muthal, Praveen Garg
Compliance Officer/s:
NA
Investor Service Officer/s:
Mr.Prashant Thakkar
Fund Manager/s:
Karan Doshi
Auditors:
S.R. Batliboi LLP

OTHER INFORMATION

Registered Office:
4th Floor, Industrial Insurance Building, Opp.Churchgate Stati Mumbai 400 020.
Contact Nos:
022-66016000
Fax:
022-22843660
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.